Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MEVAC Mycoplasma Vaccine
- Development stage
- Unknown
- Lead developer
- MEVAC
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous, Intramuscular
01
Overview
MEVAC Mycoplasma Vaccine is a veterinary biological product developed by Middle East for Vaccines (MEVAC) for the immunization of poultry against Mycoplasma infections. These infections, primarily caused by *Mycoplasma gallisepticum* (MG) and *Mycoplasma synoviae* (MS), are responsible for chronic respiratory disease, airsacculitis, and infectious synovitis in chickens and turkeys. The vaccine is designed to stimulate the avian immune system to produce specific antibodies, thereby reducing clinical signs, lesions, and the drop in egg production associated with these pathogens. It is typically formulated as an inactivated oil-emulsion vaccine to provide long-lasting immunity and is used in commercial broiler and layer operations to maintain flock health and productivity.
- Brand names
- MEVAC MGMEVAC MS
- Other names
- Mycoplasma Vaccine (Poultry)MEVAC Myco
02
Targets
MG/MS antigens (Mycoplasma gallisepticum and Mycoplasma synoviae antigens)
Beyond the preview
Go deeper on MEVAC Mycoplasma Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MEVAC Mycoplasma Vaccine.